BSE Live
Jan 20, 14:12Prev. Close
22.90
Open Price
22.90
Bid Price (Qty.)
21.75 (50)
Offer Price (Qty.)
22.47 (91)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Beryl Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | |
| Total Share Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | |
| Reserves and Surplus | 2.53 | 2.43 | 1.57 | 0.79 | 1.57 | |
| Total Reserves and Surplus | 2.53 | 2.43 | 1.57 | 0.79 | 1.57 | |
| Total Shareholders Funds | 7.63 | 7.53 | 6.67 | 5.89 | 6.66 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2.31 | 1.30 | 0.07 | 0.09 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.27 | 0.21 | 0.18 | 0.21 | 0.22 | |
| Total Non-Current Liabilities | 2.66 | 1.51 | 0.26 | 0.31 | 0.22 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2.39 | 1.76 | 1.39 | 1.60 | 1.67 | |
| Trade Payables | 1.80 | 1.79 | 1.45 | 1.16 | 0.74 | |
| Other Current Liabilities | 2.41 | 1.97 | 1.06 | 1.41 | 0.74 | |
| Short Term Provisions | 0.03 | 0.01 | 0.01 | 0.08 | 0.10 | |
| Total Current Liabilities | 6.63 | 5.53 | 3.91 | 4.24 | 3.27 | |
| Total Capital And Liabilities | 16.91 | 14.57 | 10.83 | 10.44 | 10.15 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 8.33 | 1.81 | 2.04 | 2.03 | 2.44 | |
| Intangible Assets | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 6.24 | 0.08 | 0.00 | 0.00 | |
| Other Assets | 0.26 | 0.15 | 0.17 | 0.21 | 0.00 | |
| Fixed Assets | 8.60 | 8.20 | 2.29 | 2.25 | 2.44 | |
| Non-Current Investments | 0.56 | 0.48 | 0.22 | 0.49 | 0.68 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.53 | 0.68 | 0.81 | |
| Other Non-Current Assets | 0.23 | 0.42 | 0.78 | 0.15 | 0.00 | |
| Total Non-Current Assets | 9.40 | 9.09 | 3.82 | 3.58 | 4.18 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1.16 | 0.76 | 1.35 | 2.67 | 1.54 | |
| Trade Receivables | 3.45 | 3.44 | 4.83 | 3.06 | 3.58 | |
| Cash And Cash Equivalents | 0.40 | 0.10 | 0.14 | 0.63 | 0.63 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.13 | 0.00 | 0.15 | |
| OtherCurrentAssets | 2.51 | 1.18 | 0.56 | 0.49 | 0.07 | |
| Total Current Assets | 7.51 | 5.48 | 7.01 | 6.86 | 5.97 | |
| Total Assets | 16.91 | 14.57 | 10.83 | 10.44 | 10.15 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.58 | 1.08 | 2.69 | 2.43 | 1.22 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | 0.78 | |
| Non-Current Investments Unquoted Book Value | -- | 0.48 | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
14.02.2025
Beryl Drugs Standalone December 2024 Net Sales at Rs 5.31 crore, down 30.35% Y-o-Y